Waqqas Afif

4.7k total citations
143 papers, 2.8k citations indexed

About

Waqqas Afif is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Waqqas Afif has authored 143 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Genetics, 82 papers in Epidemiology and 40 papers in Surgery. Recurrent topics in Waqqas Afif's work include Inflammatory Bowel Disease (108 papers), Microscopic Colitis (68 papers) and Immunodeficiency and Autoimmune Disorders (21 papers). Waqqas Afif is often cited by papers focused on Inflammatory Bowel Disease (108 papers), Microscopic Colitis (68 papers) and Immunodeficiency and Autoimmune Disorders (21 papers). Waqqas Afif collaborates with scholars based in Canada, Hungary and United States. Waqqas Afif's co-authors include Alain Bitton, Talat Bessissow, Edward V. Loftus, William J. Sandborn, Ernest G. Seidman, Péter L. Lakatos, William A. Faubion, Uri Kopylov, Karen A. Hanson and Sunanda V. Kane and has published in prestigious journals such as Gastroenterology, American Journal of Respiratory and Critical Care Medicine and The American Journal of Gastroenterology.

In The Last Decade

Waqqas Afif

127 papers receiving 2.8k citations

Peers

Countries citing papers authored by Waqqas Afif

Since Specialization

Citations

This map shows the geographic impact of Waqqas Afif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waqqas Afif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waqqas Afif more than expected).

Fields of papers citing papers by Waqqas Afif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waqqas Afif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waqqas Afif. The network helps show where Waqqas Afif may publish in the future.

Co-authorship network of co-authors of Waqqas Afif

This figure shows the co-authorship network connecting the top 25 collaborators of Waqqas Afif. A scholar is included among the top collaborators of Waqqas Afif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waqqas Afif. Waqqas Afif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis 2025 ·Inflammatory Bowel Diseases ·(unknown), Péter L. Lakatos, (unknown), Victoria Marcus, Waqqas Afif, Gary Wild, Alain Bitton, Cristina Flores, Carlos Fernando de Magalhães Francesconi, Talat Bessissow	0
2	Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based data 2024 ·BMC Rheumatology ·Marina Gabriela Birck, (unknown), D. Choquette, Gilles Boire, Walter P. Maksymowych, Harminder Singh, Waqqas Afif, Sasha Bernatsky	0
3	The relationship among vedolizumab drug concentrations, biomarkers of inflammation, and clinical outcomes in a Canadian real-world study 2024 ·Journal of the Canadian Association of Gastroenterology ·Cynthia H. Seow, John K. Marshall, Erin Stewart, Christopher Pettengell, Ryan Ward, Waqqas Afif	2
4	P716 Efficacy and safety of upadacitinib during induction in Crohn’s disease: Real-world experience 2024 ·Journal of Crohn s and Colitis ·(unknown), (unknown), (unknown), Waqqas Afif, Alain Bitton, Gary Wild, Neeraj Narula, Péter L. Lakatos, Talat Bessissow	1
5	Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapies 2024 ·Journal of the Canadian Association of Gastroenterology ·Vipul Jairath, Waqqas Afif, Brian Bressler, Janet Pope, Daniel Selchen, Laura E. Targownik, Remo Panaccione	2
6	Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study 2023 ·The Turkish Journal of Gastroenterology ·Panu Wetwittayakhlang, Christine Verdon, Michael Starr, (unknown), Petra A. Golovics, Talat Bessissow, Waqqas Afif, Gary Wild, Alain Bitton, Péter L. Lakatos	1
7	Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study 2023 ·Digestive and Liver Disease ·Panu Wetwittayakhlang, (unknown), (unknown), (unknown), (unknown), Waqqas Afif, Gary Wild, Alain Bitton, Talat Bessissow, Péter L. Lakatos	10
8	Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases 2023 ·Crohn s & Colitis 360 ·(unknown), (unknown), (unknown), Sophie Restellini, Alain Bitton, Gary Wild, Waqqas Afif, Péter L. Lakatos, Talat Bessissow, Giada Sebastiani	4
9	OP15 Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension 2023 ·Journal of Crohn s and Colitis ·Silvio Danese, Waqqas Afif, María T. Abreu, William J. Sandborn, Yi Miao, (unknown), (unknown), Tadakazu Hisamatsu, Ellen Scherl, Rupert W. Leong, David Rowbotham, Ramesh Arasaradnam, Laurent Peyrin‐Biroulet, B E Sands, Colleen Marano, (unknown)	2
10	P364 Patient reported outcomes, partial MAYO score and SCCAI are equally accurate in predicting mucosal healing in UC: final results form a prospective study 2021 ·Journal of Crohn s and Colitis ·Petra A. Golovics, Lóránt Gönczi, (unknown), Christine Verdon, Sheetal Pundir, Waqqas Afif, Gary Wild, Alain Bitton, Talat Bessissow, Péter L. Lakatos	0
11	Clinical Outcomes of COVID‐19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease 2021 ·Canadian Journal of Gastroenterology and Hepatology ·Panu Wetwittayakhlang, (unknown), Petra A. Golovics, (unknown), Talat Bessissow, Alain Bitton, Waqqas Afif, Gary Wild, Péter L. Lakatos	17
12	Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease 2020 ·Intestinal Research ·(unknown), (unknown), Myriam Martel, Péter L. Lakatos, Talat Bessissow, Talal Al-Taweel, Waqqas Afif	10
13	Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes 2020 ·World Journal of Gastroenterology ·(unknown), Lóránt Gönczi, Zsuzsanna Kürti, Isabelle Morin, (unknown), Christine Verdon, Jason Reinglas, Rita Kohen, Talat Bessissow, Waqqas Afif, Gary Wild, Ernest G. Seidman, Alain Bitton, Péter L. Lakatos	10
14	Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center 2019 ·Digestive Diseases and Sciences ·Jason Reinglas, Lóránt Gönczi, Christine Verdon, Talat Bessissow, Waqqas Afif, Gary Wild, Ernest G. Seidman, Alain Bitton, Péter L. Lakatos	12
15	High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival 2018 ·Digestive Diseases and Sciences ·Che‐Yung Chao, Alex Al Khoury, (unknown), Sophie Restellini, Jonathan Wyse, Waqqas Afif, Alain Bitton, Péter L. Lakatos, Talat Bessissow	18
16	Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies 2017 ·Digestive and Liver Disease ·Lóránt Gönczi, Zsuzsanna Kürti, Petra A. Golovics, Barbara D. Lovász, (unknown), (unknown), (unknown), (unknown), Ákos Iliás, (unknown), K Gecse, (unknown), Waqqas Afif, Alain Bitton, Zsuzsanna Végh, Péter L. Lakatos	10
17	Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease 2016 ·Inflammatory Bowel Diseases ·Talat Bessissow, (unknown), (unknown), Waqqas Afif, Alain Bitton, Giada Sebastiani	90
18	The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients 2015 ·Journal of Crohn s and Colitis ·Triana Lobatón, Talat Bessissow, Gert De Hertogh, Bart Lemmens, (unknown), Gert Van Assche, Séverine Vermeire, Raf Bisschops, Paul Rutgeerts, Alain Bitton, Waqqas Afif, Victoria Marcus, Marc Ferrante	110
19	Safety Profile of IBD Therapeutics: Infectious Risks 2009 ·Medical Clinics of North America ·Waqqas Afif, Edward V. Loftus	16
20	Dichotomy between Neurokinin Receptor Actions in Modulating Allergic Airway Responses in an Animal Model of Helper T Cell Type 2 Cytokine-associated Inflammation 2000 ·American Journal of Respiratory and Critical Care Medicine ·Karim Maghni, Rame Taha, Waqqas Afif, Qutayba Hamid, James G. Martin	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact